11661
Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition(s):LeukemiaLast Updated:December 28, 2017Completed
HIV Infections: 11753 Clinical Trials, Page 1167 of 1176
Hide Studies Not Open or Pending
11662
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer
Condition(s):Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell NeoplasmLast Updated:September 21, 2010Completed
11663
Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases
Condition(s):MelanomaLast Updated:August 19, 2011Completed
11664
Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin’s Lymphoma
Condition(s):LymphomaLast Updated:December 29, 2009Completed
11665
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous/Nonmalignant Condition; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:May 12, 2011Completed
11666
Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma
Condition(s):Melanoma (Skin)Last Updated:March 29, 2012Terminated
11667
High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
Condition(s):Kidney Cancer; Melanoma (Skin)Last Updated:May 12, 2011Completed
11668
Biological Therapy in Treating Patients With Metastatic Cancer
Condition(s):Kidney Cancer; Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:May 11, 2011Completed
11669
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Condition(s):Recurrent Renal Cell Carcinoma; Stage IV Renal Cell CancerLast Updated:June 30, 2015Completed
11670
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
Condition(s):Kidney CancerLast Updated:June 26, 2018Completed